Behind the Scenes of a Billion Dollar Pharma Deal
On 9 June 2020 Eli Lilly and Evox Therapeutics inked a neuroscience therapy deal worth $1.2 billion.
In this webinar two of the key players in that deal will take you behind-the-scenes to explain how Evox got on Lilly’s radar, explore the challenges of forming a partnership under a COVID-19 lockdown, and recall the discussions and internal debates that led to one of the biggest biopharma deals of the year so far.
Please complete the form below
All fields marked with a * are required.
personal data by Inova as detailed in the Privacy Statement.